Cargando…
Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors
BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545215/ https://www.ncbi.nlm.nih.gov/pubmed/35384179 http://dx.doi.org/10.1111/jar.12996 |
_version_ | 1784804769368375296 |
---|---|
author | García‐Domínguez, Laura Navas, Patricia Verdugo, Miguel Ángel Arias, Víctor B. Gómez, Laura E. |
author_facet | García‐Domínguez, Laura Navas, Patricia Verdugo, Miguel Ángel Arias, Víctor B. Gómez, Laura E. |
author_sort | García‐Domínguez, Laura |
collection | PubMed |
description | BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual disability, their psychotropic medication intake, and the factors contributing to a greater medication intake. METHOD: The sample consisted of 991 people with intellectual disability over 45 years. Descriptive statistics and multinominal logistic regression were carried out. RESULTS: Antipsychotics were the most used psychotropic drug. Older people with mild intellectual disability living in institutions and affected by mental health and behavioural problems were more likely to take larger amounts of psychotropic medication. CONCLUSIONS: Antipsychotics continue to be widely used by people with intellectual disability and mental and behavioural health problems, especially those in institutionalised settings. Future research should consider if medication intake could be reduced providing better supports in the community and non‐pharmacological interventions. |
format | Online Article Text |
id | pubmed-9545215 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-95452152022-10-14 Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors García‐Domínguez, Laura Navas, Patricia Verdugo, Miguel Ángel Arias, Víctor B. Gómez, Laura E. J Appl Res Intellect Disabil Original Articles BACKGROUND: Psychotropic medication is frequently administered to people with intellectual disability with mental health and/or behavioural problems, instead of other non‐pharmacological interventions. This study describes the mental health and behavioural problems of people aging with intellectual disability, their psychotropic medication intake, and the factors contributing to a greater medication intake. METHOD: The sample consisted of 991 people with intellectual disability over 45 years. Descriptive statistics and multinominal logistic regression were carried out. RESULTS: Antipsychotics were the most used psychotropic drug. Older people with mild intellectual disability living in institutions and affected by mental health and behavioural problems were more likely to take larger amounts of psychotropic medication. CONCLUSIONS: Antipsychotics continue to be widely used by people with intellectual disability and mental and behavioural health problems, especially those in institutionalised settings. Future research should consider if medication intake could be reduced providing better supports in the community and non‐pharmacological interventions. Blackwell Publishing Ltd 2022-04-05 2022-09 /pmc/articles/PMC9545215/ /pubmed/35384179 http://dx.doi.org/10.1111/jar.12996 Text en © 2022 The Authors. Journal of Applied Research in Intellectual Disabilities published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Articles García‐Domínguez, Laura Navas, Patricia Verdugo, Miguel Ángel Arias, Víctor B. Gómez, Laura E. Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title | Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title_full | Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title_fullStr | Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title_full_unstemmed | Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title_short | Psychotropic drugs intake in people aging with intellectual disability: Prevalence and predictors |
title_sort | psychotropic drugs intake in people aging with intellectual disability: prevalence and predictors |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545215/ https://www.ncbi.nlm.nih.gov/pubmed/35384179 http://dx.doi.org/10.1111/jar.12996 |
work_keys_str_mv | AT garciadominguezlaura psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors AT navaspatricia psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors AT verdugomiguelangel psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors AT ariasvictorb psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors AT gomezlaurae psychotropicdrugsintakeinpeopleagingwithintellectualdisabilityprevalenceandpredictors |